ASP Isotopes downsizes proposed IPO to $7M from $12M (Pending:ASPI)

ASP Isotopes (ASPI) has downsized its proposed preliminary public providing to $7M from $12M.

In its newest submitting, the corporate stated that it’s now seeking to provide 1.5M shares priced from $4 to $5, which might increase round $7M if priced on the midpoint.

As well as, sure promoting shareholders plan to supply 2M shares on the identical value, which might increase $9M. The corporate would not obtain any proceeds from the sale.

In an earlier submitting, ASP stated that it was planning to supply 2M shares priced between $5 and $7, which might have raised round $12M if priced on the midpoint.

The corporate hopes to listing its shares on Nasdaq beneath the image ASPI.

Primarily based in Florida, ASP is creating know-how for improved isotope manufacturing. The corporate is initially specializing in know-how to provide Molybdenum-100 for nuclear medical imaging and Uranium-235 for nuclear energy technology.

For extra a extra in-depth take a look at the corporate, take a look at SA contributor Donovan Jones’s “ASP Isotopes Proposes $12M US IPO”.